Hormonal therapy in the management of prostate cancer: From Huggins to the present
- 1 March 1997
- Vol. 49 (3) , 5-15
- https://doi.org/10.1016/s0090-4295(97)00163-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate CancerJournal of Urology, 1996
- Estrogens in the Treatment of Prostate CancerJournal of Urology, 1995
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate CancerJournal of Urology, 1995
- Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate CancerNew England Journal of Medicine, 1995
- Neoadjuvant Hormonal Downsizing of Localized Carcinoma of the Prostate: Effects on the Volume of Normal Tissue IrradiationCancer Investigation, 1995
- Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonistUrology, 1994
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)New England Journal of Medicine, 1989
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984